Please assess the completion status of the following clinical trial:

Trial Title: LymphoPilot Test for Limb Lymphedema

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Female patients, 18 years and older~* Patients with unilateral secondary upper or lower limb lymphedema.~Exclusion Criteria:~* Active cellulitis/infection~* Lymphedema associated with active cancer requiring chemotherapy or radiotherapy~* Motor and sensitive neurological deficiency~* Post-operative edema (i.e. acute edema following breast cancer related surgery)~* Any contraindication to surgery or to loco-regional or general anesthesia~* Patient participating in any other clinical study~* Patient unable to provide informed consent~* Patient with pacemaker~* Pathologies associated with an overload of the cardiac system~* Poor wound healing~* Pregnancy or breastfeeding~* Known intolerance to implantable devices~* Known allergies to silicone~* Patient needing magnetic therapy~* Any other condition that according to the principal investigator makes the patient unsuitable for the participation in the trial~* Patient refusing to receive information about incidental findings on her health status discovered during the clinical investigation~* L-Dex score lower than 6.5 at screening

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LymphoPilot (Type: EXPERIMENTAL): Patient will be implanted with the medical device under investigation, LymphoPilot, through a surgical procedure performed in loco-regional or general anesthesia. Lymphedema outcomes will be monitored for 8 weeks after implantation and compared to baseline values before device implantation. Safety data will be collected throughout the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).